SPERGILLUS infections have grown in importance in the last few decades. However, most of the studies have focused on Aspergillus fumigatus, the most prevalent species in the human infections which is followed by Aspergillus flavus . Eventhough Aspergillus flavus was more common than A. fumigatus in some reports. Aspergillus niger came next to them causing invasive aspergillosis . Aspergillus flavus is a widely feared fungal pathogen capable of producing aflatoxin, the most potent mycotoxin . Two hundred and fifty hospitalized patients were studied for fungal infection. Out of the collected cases 109 were positive fungal infection representing 43.6% of the total cases. The age of the patients ranged from 22 to 68 years, of which 61% were male and 39% were female. Three species of the genus Aspergillus were collected from 18 cases representing 16.5% of the total positive. These isolates identified as Aspergillus flavus (11 cases ) followed by A .niger (5 cases ) and A. fumigatus ( 2 cases ) representing 10.1%, 4.6% and 1.8% , respectively. Identification was carried out using the traditional method and confirmed by the molecular techniques (amplification of the internal transcribed spacer 2 (ITS2) region and direct sequencing followed by comparative GenBank analysis ). All the isolates were tested for aflatoxin production using High Performance Liquid Chromatography (HPLC). Aflatoxins B1 and B2 were produced from A. flavus only while A. niger and A. fumigatus were non-producers. Voriconazole (200 mg/12h for 12 weeks) and Micafungin (100-150 mg/day for 12 weeks) were successfully used for treating all the cases.
infection and has been considered second leading cause of aspergillosis (Denning, 1998 and Morgan et al., 2005) . A. flavus is unique in being both plant and human pathogen. A. flavus and A. parasiticus are the major producers of mycotoxins (aflatoxins) that contaminant cereal grains such as groundnut, maize, etc., a leading to economic losses (Shankar et al., 2005) . A person can inhale several hundred conidia of A. fumigatus per day (Latge, 1999) . Although the spores of A. fumigatus are found in a small proportion of all the airborne spores within a hospital (approximately 0.3%). Approximately 30% to 90% of the systemic infections are due to Aspergillus (Brakhage & Langfelder, 2002) . A. fumigatus has gained importance because it easily causes infection in immunocompromised patients.
Human body temperature appears to provide the ideal condition for the development of invasive disease due to A. fumigatus and reducing the impact by other Aspergillus species such as A. flavus, and A. niger (Araujo & Rodrigues, 2004) . The most common clinical manifestation of infection by Aspergillus species is invasive aspergillosis with mortality higher than 90%. A. fumigatus, A. flavus, A. niger and A. terreus are frequently isolated from airways (nose, throat, bronchi) of such patients, and colonization could lead to invasive aspergillosis (Kosalec & Pepeljnjak, 2005) . Aflatoxins (AFB1, AFB2, AFG1, AFG2, and AFM1) are mycotoxins produced by A. flavus, A. parasiticus and A. nomius strains. The production of the major toxins are a result of particular strains of A. flavus, B1 is the most common and most toxic (Hedayati et al., 2007) . Aflatoxins also show a wide range of immunotoxic effects, they depress phagocytosis, intracellular killing and spontaneous superoxide production of macrophages (Cusumona et al., 1990 and Hinton et al., 2003) . Aflatoxin B1 also inhibits the production of the tumor-necrosis factor (TNF), population interleukin-1 (IL1) and IL-6 by lipopolysaccharide-stimulated macrophages (Moon et al., 1999) . This study aimed to study aflatoxin production from aspergilli isolated from immunocompromised hospitalized patients. In humans, A. flavus aflatoxin production can lead to acute hepatitis, immunosuppression, hepatocellular carcinoma, and neutropenia. It is highly possible for A. flavus to invade arteries of the lung or brain and cause infarction. The absence of any regulation of screening for the fungus in countries that also have a high prevalence of viral hepatitis highly increases the risk of hepatocellular carcinoma (Crawford, 2005) .
Micafungin is a natural product derived from other fungi as a defense mechanism for competition of nutrients. Micafungin is produced by Coleophoma empetri (Hashimoto, 2009 and Fujie & Akihiko, 2007) . Micafungin (trade name Mycamine) is an echinocandin antifungal drug. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls . Micafungin is indicated for the treatment of candidiasis and other opportunistic mycosis (Pappas et al., 2007 ) . Voriconazole is a triazole antifungal medication that is generally seen in patients who are immmunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections .Voiconazole has become the new standard of care in treatment of invasive aspergillosis .Voriconazole is more effective than other azole drugs in blocking sterol biosynthesis, consistent with the different antifungal potencies of these compounds .
Materials and Methods

Study population
This study included 250 immunocompromised hospitalized patients at Ain Shams University Hospitals ( Ain Shams University ) during the year June 2012-May 2013. The microbiology laboratory records were reviewed daily. The corresponding medical records were reviewed and the clinical data analyzed included demographic characteristics, site of infection, host factors and the type of underlying disease at the time of diagnosis of the infection.
Sampling, culturing and strain identification
The collected sputum, urine, blood, bile, ascetic fluid, pleural fluid, pus, and throat swab samples were directly cultured on Sabouraud dextrose agar (SDA) and potato dextrose agar (PDA). The obtained isolates were identified through examination of micro-and macro-morphologic features in accordance with standard morphological criteria (Gonzalez et al., 2008; Ribes et al., 2000.; Madhavan et al., 2011; de Hoog et al., 2011 and Gomes et al., 2011) . In addition to the traditional method of identification, molecular techniques were used by comparing the ITS1-5.8S-ITS2 rDNA region sequence data of the isolated strains with reference strains data deposited in GenBank.
Extraction of DNA
Fungal isolates were grown on PDA. DNA extracted from the fungal isolates mentioned was conducted in accordance with the instructions provided by Fermentas Genomic DNA Purification Kit #K0512 (Thermo Fischer Scientific, EU). Briefly, a sufficient inoculum was suspended in 200 μl TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) in a 2.2 ml Eppendorf tube, the tubes were boiled for 3 min and then placed in ice water for 10 min. Lysis solution (400 μl) was added, the tubes heated to 65C for 30 min and then 600 μl of chloroform were added and mixed carefully. The aqueous phase containing DNA was separated by centrifugation for 10 min at 12,000 rpm at 4C and mixed with 800 μl precipitation solution by several inversions at room temperature for 1 min each. The tubes were then centrifuged for 10 min at 12,000 rpm at 4C. The DNA pellets were dissolved in 100 μl of 1.2 M NaCl solution by gentle vortexing. Ice cold isopropanol (500 μl) was added to the solution, the tubes were incubated for 15 min at − 20C and then centrifuged for 10 min at 12,000 rpm at 4C. The DNA pellet was washed with 1 ml ice cold 70% ethanol, dried and re-suspended in sterile TE buffer.
Oligonucleotides
The oligonucleotide primers used for amplification and sequencing of the ITS regions were those described by White et al., (1990) . This study used ITS5 (5 -GGAAGTAAA AGTCGTAACAAGG-3) and ITS4 (5 -TCCTCCGCTTATTGATATGC-3) (Bioneer Corporation, South Korea). PCR and DNA sequencing of ITS1-5.8S-ITS2 region rDNA of fungal species.
Amplification reactions were performed in 20 μl reaction mixture containing 2.5 μl of each primer (10 pm), 2.5 μl of genomic DNA (5 μg/ml), and one PCR-Gold MasterMix bead (Bioron-Germany; buffers, dNTP, enzyme, stabilizers, Tris-HCl, KCl, and MgCl 2 ). Amplification was performed with a PCR Thermal Cycler (Techne Genius -UK) using the initial denaturation at 96C for 5 min, 35 cycles of denaturation at 94C for 30 sec, annealing at 52C for 30 sec, extension at 72C for 80 sec, and a final extension at 72C for 10 min. The PCR reaction products were sequenced directly using a Big-Dye terminator reagent kit including Taq polymerase and the protocol recommended by the manufacturer (Model 3100 automated DNA sequencer; PerkinElmer Inc./ Applied Biosystems -Bioneer, South Korea).
Aflatoxin production
All the Aspergillus isolates were tested for the production of aflatoxin based on the HPLC (Frisvad & Thrane, 1993) . The analytical standards (aflatoxins B1& B2) was purchased from Sigma (St. Louis, MO), and a stock solution was prepared in acetonitrile/methanol (1:1) and stored in an amber vial in a freezer (ca-18C). Malt extract (MEA) ,liquid medium, was used for obtaining culture filtrate that is used in studying aflatoxin production by fungal tested strains.
High performance thin layer chromatography (HPLC)
After 14 days of incubation, the mate and the filtrate were defatted with n-hexane extracted using chloroform. The chloroform layer was collected then evaporated and concentrated then re-dissolved in 1 ml chloroform.
Twenty microliters of the extracted samples were applied to HPLC plates (20cm x20 cm, silica gel 60 precoated plate, Merck Darmstadt, Germany) and developed with a 5:4:1 (v/v/v) mixture of toluene: ethyl acetate : formic acid for 17 cm then scanned using CAMMAG TLC scanner system at the Regional Centre for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt. Aflatoxin analogues were detected as a bluish spot under UV-A (365 nm) illumination and were compared with authentic standard as well as griseofulvin (Frisvad & Thrane, 1993) .
Results
Identification of isolates
Out of 250 hospitalized patients included in this study, they were categorized according to their underlying diseases (Table 1) . Of the collected samples, a total of 109 cases (43.6%) were positive for fungal infection while 141(56.4%) were considered negative. The highest number of patients positive for fungal infections were diabetes mellitus and chronic pulmonary disease patients (25 cases) and the least number of positive fungal infections were among liver cell failure (LCF) patients (2 cases) (Fig. 1) . The recorded positive percentages among the studied patients showed high significance (P value <0.001).
Three species of Aspergillus were recovered (16.5%) (Fig. 2) . Aspergillus flavus was the most frequently recovered since it was isolated from 11 cases (10.1%) followed by Aspergillus niger 5 cases which represented (4.6%) while Aspergillus fumigatus was isolated from 2 cases representing (1.8%). Concerning the site of infection 9 cases of Aspergillus were recovered from pulmonary infection, 7 cases renal infection and 2 cases cutaneous infection (Tables 2, 3) . Molecular identification of the recovered isolates based on the sequence of the ITS1-5.8S-ITS2 ribosomal DNA region revealed that the Aspergillus flavus was highly identical (>99%) to the reference strain Aspergillus flavus (GenBank Accession No. JX028197) and the pair wise alignment between the recovered strain and the reference strain through blast homology search on gen bank database (NCBI) is shown in Fig. 3 .
CLUSTAL W (1.83) multiple DNA sequence alignment
A. flavus recovered CTCCCCCCGTGTTTACTGTACCTTAGTTGCTTCGGCGGGCCCGCCATTCATG GCCGCCGG A. flavus reference CTCCCCCCGTGTTTACTGTACCTTAGTTGCTTCGGCGGGCCCGCCATTCATGGC CGCCGG *********************************************************************** A. flavus recovered GGGCTCTCAGCCCCGGGCCCGCGCCCGCCGGAGACACCACGAACTCTGT CTGATCTAGTG A. flavus reference GGGCTCTCAGCCCCGGGCCCGCGCCCGCCGGAGACACCACGAACTCT GTCTGATCTAGTG **************************************************************** A. flavus recovered AAGTCTGAGTTGATTGTATCGCAATCAGTTAAAACTTTCAACAATGGATCT CTTGGTTCC A. flavus reference AAGTCTGAGTTGATTGTATCGCAATCAGTTAAAACTTTCAACAATGGATCTCTTGG TTCC *********************************************************************** A. flavus recovered GGCATCGATGAAGAACGCAGCGAAATGCGATAACTAGTGTGAATTGCAGA ATTCCGTGAA A. flavus reference GGCATCGATGAAGAACGCAGCGAAATGCGATAACTAGTGTGAATTGCA GAATTCCGTGAA ******************************************************************* A. flavus recovered TCATCGAGTCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGGGGCATG CCTGTCCGA A. flavus reference TCATCGAGTCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGGGGCATGCCT GTCCGA *********************************************************************** A. flavus recovered GCGTCATTGCTGCCCATCAAGCACGGCTTGTGTGTTGGGTCGTCGTCCCCTCTC CGGGGG A. flavus reference GCGTCATTGCTGCCCATCAAGCACGGCTTGTGTGTTGGGTCGTCGTCCCCTCTC CGGGGG *********************************************************************** A. flavus recovered GGACGGGCCCCAAAGGCAGCGGCGGCACCGCGTCCGATCCTCGAGCGTAT GGGGCTTTGT A. flavus reference GGACGGGCCCCAAAGGCAGCGGCGGCACCGCGTCCGATCCTCGAGCGTATGG GGCTTTGT *********************************************************************** A. flavus recovered CACCCGCTCTGTAGGCCCGGCCGGCGCTTGCCGAACGCAAATCAATCTT TTTCCAGGTTG A. flavus reference CACCCGCTCTGTAGGCCCGGCCGGCGCTTGCCGAACGCAAATCAATCTTTTTCC AGGTTG *********************************************************************** A. flavus recovered ACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAA A. flavus reference ACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAA ******************************************** *************** Aspergillus niger was highly identical (>99%) to reference strain Aspergillus niger (GenBank Accession No.KF358715) and the pair wise alignment between the recovered strain and the reference strain through blast homology search on gen bank database (NCBI) is shown in Fig. 4 .
A.niger recovered AGTGCGGGTCCTTTGGGACCCAACCTC
A.niger reference AGTGCGGGTCCTTTGGGACCCAACCTC **********************************
A.niger recovered CCATCCGTGTCTATTGTACCCTGTTGCTTCGGCGGGCCCGCCGCTTGTCGGC CGCCGGGG
A.niger reference CCATCCGTGTCTATTGTACCCTGTTGCTTCGGCGGGCCCGCCGCTTGTCG GCCGCCGGGG ********************************************** ****************** A.niger recovered GGGCGCCTCTGCCCCCCGGGCCCGTGCCCGCCGGAGACCCCAACACGA ACACTGTCTGAA ****************************************************************
A.niger reference GGCATCGATGAAGAACGCAGCGAAATGCGATAACTAGTGTGAATTGCA GAATTCCGTGAA
A.niger recovered AGCGTGCAGTCTGAGTTGATTGAATGCAATCAGTTAAAACTTTCAACAATG GATCTCTTG
A.niger reference AGCGTGCAGTCTGAGTTGATTGAATGCAATCAGTTAAAACTTTCAACAATG GATCTCTTG ******************************************* ********************* A.niger recovered GTTCCGGCATCGATGAAGAACGCAGCGAAATGCGATAACTAATGTGAATT GCAGAATTCA A.niger reference GTTCCGGCATCGATGAAGAACGCAGCGAAATGCGATAACTAATGTGAATT GCAGAATTCA ** ******************************************** ****************** A.niger recovered GTGAATCATCGAGTCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGG GGCATGCCTG A.niger reference GTGAATCATCGAGTCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGG GGCATGCCTG ********************************* ************* ******************
A.niger recovered TCCGAGCGTCATTGCTGCCCTCAAGCCCGGCTTGTGTGTTGGGTCGCCG TCCCCCTCTCC
A.niger reference TCCGAGCGTCATTGCTGCCCTCAAGCCCGGCTTGTGTGTTGGGTCGCCG TCCCCCTCTCC ********************************************** ***************** * A.niger recovered GGGGGGACGGGCCCGAAAGGCAGCGGCGGCACCGCGTCCGATCCTCGA GCGTATGGGGCT A.niger reference GGGGGGACGGGCCCGAAAGGCAGCGGCGGCACCGCGTCCGATCCTCGA GCGTATGGGGCT ****************************************************** A.niger recovered TTGTCACATGCTCTGTAGG A.niger reference TTGTCACATGCTCTGTA ********************* Aspergillus fumigatus was highly identical (>99%) to reference strain Aspergillus fumigatus (GenBank Accession No. KF201647) and the pair wise alignment between the recovered strain and the reference strain through blast homology search on gen bank database (NCBI) is shown in Fig. 5 .
CLUSTAL W (1.83) multiple DNA sequence alignment
A.fumigatus recovered CCGTGTCTATCGTACCTTGTTGCTTCGGCGGGCCCGCCGTTTCG
A.fumigatus reference CCGTGTCTATCGTACCTTGTTGCTTCGGCGGGCCCGCCGTTTCG ****************** ************ **************************
A.fumigatus recovered ACGGCCGCCGGGGAGGCCTTGCGCCCCCGGGCCCGCGCCCGCCGA AGACCCCAACATGAA
A.fumigatus reference ACGGCCGCCGGGGAGGCCTTGCGCCCCCGGGCCCGCGCCCGCCGA AGACCCCAACATGAA ****************** ************ ****************** ******** A.fumigatus recovered CGCTGTTCTGAAAGTATGCAGTCTGAGTTGATTATCGTAATCAGTTAAA ACTTTCAACAA A.fumigatus reference CGCTGTTCTGAAAGTATGCAGTCTGAGTTGATTATCGTAATCAGTTAAA ACTTTCAACAA ****************** ************ **************************
A.fumigatus recovered CGGATCTCTTGGTTCCGGCATCGATGAAGAACGCAGCGAAATGCGAT AAGTAATGTGAAT A.fumigatus reference CGGATCTCTTGGTTCCGGCATCGATGAAGAACGCAGCGAAATGCGAT AAGTAATGTGAAT
****************** ************ **************************
A.fumigatus recovered TGCAGAATTCAGTGAATCATCGAGTCTTTGAACGCACATTGCGCCCCC TGGTATTCCGGG
A.fumigatus reference TGCAGAATTCAGTGAATCATCGAGTCTTTGAACGCACATTGCGCCCCC TGGTATTCCGGG ****************** ************ **************************
A.fumigatus recovered GGGCATGCCTGTCCGAGCGTCATTGCTGCCCTCAAGCACGGCTTGTG TGTTGGGCCCCCG A.fumigatus reference GGGCATGCCTGTCCGAGCGTCATTGCTGCCCTCAAGCACGGCTTGTG TGTTGGGCCCCCG
A.fumigatus recovered TCCCCCTCTCCCGGGGGACGGGCCCGAAAGGCAGCGGCGGCACCG CGTCCGGTCCTCGAG
A.fumigatus reference TCCCCCTCTCCCGGGGGACGGGCCCGAAAGGCAGCGGCGGCACCG CGTCCGGTCCTCGAG ****************** ************ ************************** A.fumigatus recovered CGTATGGGGCTTTGTCACCTGCTCTGTAGGCCCGGCCGGCGCC A.fumigatus reference CGTATGGGGCTTTGTCACCTGCTCTGTAGGCCCGGCCGGCGCC **** **** ********* *************************************** 
Aflatoxin analysis
Among the 18 isolates of Aspergillus tested for aflatoxin production by HPLC method, A. flavus isolates were the aflatoxin producers, while A. niger and A. fumigatus were non producers (Fig. 6, 7) . The result of scoring the intensity of the bands on HPLC plates revealed that all aflatoxinogenic isolates were able to yield aflatoxins B1 and B2 . 
Discussion
Weakening of specific immunological and non-specific host defences may predispose Aspergillus infections in debilitated and immunocompromised patients in hospitals (Kothary et al., 1984 and Bondy& Pestlea, 2000) . One hundred and nine cases (43.6%) were positive fungal infection out of 250 immunocompromised patients diagnosed in the present study. Multiple risk factors in patients of this study were, D M & COPD (33.6%), chronic granulomatous disease (4.5%), LCF (2.3%), RF (10.4%), Solid organ transplantation (6.3%), Bronchogenic carcinoma (6.3%), Lymphoma (6.3%), haematological malignancies (18.1%), and diabetic foot (11.8%) which is in line with Meersseman et al.( 2004) , Vandewoude et al. (2006) and Prakash et al. (2014) . Prakash et al. (2014) (1 of 6) and diabetic foot (2 of 30). In the present study three species of Aspergillus were identified (16%), Aspergillus flavus was the most frequently recovered since it was isolated from 11 cases (10.4%) followed by Aspergillus niger from 5 cases (4.2%) and Aspergillus fumigatus was isolated from 2 cases (2.1%). Carpagnano et al. (2014) confirmed 5 cases (11.6%) of A. niger and 3 cases (6%) of A.ochraceus out of 43 lung cancer patients while the present results showed that, 2 cases (1.8%) of A. flavus and 2 cases (1.8%) of A. niger were isolated from 16 bronchogenic carcinoma patients . Aspergillus species were isolated from 24 cases (23.3%) out of 103 studied immunocompromised hospitalized patients,. Aspergillus fumigatus was the predominant species isolated from 13 cases (54.16%) followed by Aspergillus flavus from 7 cases (29.16%) , Aspergillus niger from 3 cases (12.5 %) and Aspergillus terreus from 1 case (4.16%). The results of this study revealed that the prevalence of pulmonary aspergillosis was 8.2% while others reported 8% (Pepy et al., 1959 ), 8.2 (Campbell& Clayton, 1964 , 11% (Henderson et al., 1968) and 23.3% (Prakash et al., 2014) . Haq et al. (2007) described a case of localized renal aspergillosis in diabetic patients, Washawasky et al. (1975) and Godec et al. (1989) reported few cases of renal aspergillosis, while 7 cases were reported in the present study. Urinary tract aspergillosis due to A. flavus is rare with few reported cases (Khan et al., 1995; Perez-Arellano et al., 2001 and Kueter et al., 2002) as we isolated 5 cases of A. falvus in this study.
Aflatoxins are secondary metabolites produced namely by members of the Aspergillus flavus and A. parasiticus (Hedayati et al., 2007) , and they cause diseases in poultry and domestic animals (Bondy & Pestlea, 2000) . However, little is known about production of aflatoxins by clinical isolates of A. flavus (strains isolated from immunocompromised patients). Shanker (2013) reported that A. flavus and A. fumigatus produce gliotoxin and aflatoxin in vivo, allow invasion in the host and they are involved in immunosuppression of the host contributing to pathogenesis. Kosalec & Pepeljnjak (2005) detected aflatoxin B1 in 7 cases (23%) and aflatoxin G1 in one case (3%) out of 30 clinical isolates of A. flavus collected from immunocompromised patients in a haematological unit. Also they detected aflatoxins B1 and G1 in 11 cases (37%) and one case (3%) out of 30 environmental isolates of A. flavus. Considering this, in the present study A. flavus produced aflatoxins B1 and B2 while isolates of A. niger and A. fumigatus were not producers of aflatoxins. In recent years treatment with Voriconazole controlled aspergillosis in immunosuppressed patients (Patterson et la., 2005 and Agarwal & Singh, 2006) . In this study the 18 cases with Aspergillus infection were successfuly treated with Voriconazole. Herbrecht et al. (2002) reported that Voriconazole proved superior to Amphotercin B with 53% complete or partial response, compared with 32% for Amphotercin B .
Conclusion
In this study Aspergillus flavus was the most frequent Aspergillus spp. causing human infections. The importance of this fungus increases in regions with a dry and hot climate. A. flavus isolates produce aflatoxins, the most potent hepatocarcinogenic natural toxin. In this study the in vitro production of toxic secondary metabolites -aflatoxins from the collected isolates of Aspergillus spp. isolated from immunocompromised patients was investigated. Results of aflatoxin production, including aflatoxin B1 and B2, was produced by A. flavus isolates only. In conclusion, the incidence of Aspergillus flavus was relatively high in this study and proved its ability of afaltoxin production. More investigations are needed to clear the role of aflatoxin in pathogenesis. Voriconazole proved its efficacy in treating the aspergillosis cases in this study .
